Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-031090

FATE THERAPEUTICS INC · FATE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amir Nashat
Director
Period of report
Dec 12, 2018
Accepted (ET)
Dec 14, 2018 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 12, 2018S410,097$16.7828D1,980,561ISee Footnote
Common StockF1,F3Dec 12, 2018S7,993$16.7828D1,972,568ISee Footnote
Common StockF1,F4Dec 12, 2018S2,809$16.7828D1,969,759ISee Footnote
Common StockF1,F5Dec 12, 2018S4,101$16.7828D1,965,658ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses